Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction-Reference-Cited by-同舟云学术

Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction

Published:2020-07-22 Issue:9 Volume:40 Page:2228-2241
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Uschner Frank E.¹^ORCID,Glückert Kathleen²,Paternostro Rafael³⁴^ORCID,Gnad Thorsten⁵^ORCID,Schierwagen Robert¹,Mandorfer Mattias³⁴^ORCID,Magdaleno Fernando²,Ortiz Cristina¹,Schwarzkopf Katharina¹^ORCID,Kamath Patrick S.⁶,Alessandria Carlo⁷,Boesecke Christoph²,Pfeifer Alexander⁵^ORCID,Reiberger Thomas³⁴^ORCID,Kreisel Wolfgang⁸^ORCID,Sauerbruch Tilman¹,Ferlitsch Arnulf³⁴,Trebicka Jonel¹⁹^ORCID,Klein Sabine¹

Affiliation:

1. Department of Internal Medicine I Hospital of the Goethe University Frankfurt Germany

2. Department of Internal Medicine I University Hospital Bonn Bonn Germany

3. Hepatic Hemodynamic Lab Medical University Vienna Vienna Austria

4. Division of Gastroenterology & Hepatology Department of Internal Medicine III Medical University of Vienna Vienna Austria

5. Institute of Pharmacology and Toxicology, University Hospital University of Bonn Bonn Germany

6. Division of Gastroenterology and Hepatology Department of Internal Medicine Mayo Clinic Rochester MN USA

7. Division of Gastroenterology and Hepatology Città della Salute e della Scienza Hospital Turin Italy

8. Department of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Faculty of Medicine, Medical Center ‐ University of Freiburg Freiburg Germany

9. European Foundation for the Study of Chronic Liver Failure Barcelona Spain

Funder

Deutsche Forschungsgemeinschaft

Fundación Cellex

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14586

Reference48 articles.

1. The Endothelium-Dependent Nitric Oxide–cGMP Pathway